fda warning letters glp-1 october 2025 news GLP-1 Receptor Agonists and vision

The inability to consistently access sufficient and nutritious food affects an individual's ability to adhere to an obesity treatment plan, particularly given the importance of dietary modifications to optimize the benefits of GLP-1 use, reduce nutrient shortfalls, and manage side effects

Always inform your PlexusDx healthcare provider before adding any supplement, as some may interact with semaglutide or affect your treatment response

You can also check your Premera coverage directly by logging into the Premera members portal

According to the manufacturer, the product is described as featuring: A plant-based formula Transdermal application format Ingredients including berberine and chromium The manufacturer states the patches are designed with the goal of supporting: Appetite signaling pathways Metabolic function Balanced wellness Manufacturing Context (Per the Company) According to the NuraPatch FAQ, the product is "made in facilities that follow FDA guidelines for dietary supplements." The company states that as a "plant-based wellness product and not a prescription drug, it does not need separate FDA approval for drugs." This language aligns with standard dietary supplement regulatory positioning under the Dietary Supplement Health and Education Act (DSHEA)

(4, 9, 18) Keeping track of your food intake using MyFitnessPal can help you to see what may be impacting your weight loss efforts

As recently highlighted at the ACS Clinical Congress 2025, bariatric surgery was originally developed as a weight-loss procedure yet we discovered it could improve or even resolve type 2 diabetes